Press Releases | NeoGenomics Laboratories

Presented: April 3, 2020

NeoGenomics Integrates HALO(R) From Indica Labs

Presented: April 1, 2020

NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020

Presented: March 2, 2020

NeoGenomics Announces Three-Year Contract to be Cornerstone Oncology and Cancer Testing Laboratory for Large, National Group Purchasing Organization

Presented: February 28, 2020

NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference

Presented: February 27, 2020

NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter

Presented: February 6, 2020

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2019 Earnings Release for February 27, 2020

Presented: February 5, 2020

NeoGenomics Announces Leadership Appointments

Presented: January 10, 2020

NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million

Presented: December 6, 2019

EBV-Positive Primary Large B-Cell Lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal Lymphomas

Presented: December 3, 2019

Being Comprehensive in Hematologic Malignancies

Presented: November 6, 2019

NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference